| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.29 | 9e-10 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0003 |